A detailed history of Simplify Asset Management Inc. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Simplify Asset Management Inc. holds 75,193 shares of SNDX stock, worth $1.42 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
75,193
Previous 75,337 0.19%
Holding current value
$1.42 Million
Previous $1.79 Million 13.94%
% of portfolio
0.11%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$18.82 - $23.79 $2,710 - $3,425
-144 Reduced 0.19%
75,193 $1.54 Million
Q1 2024

May 13, 2024

BUY
$19.71 - $24.57 $1.25 Million - $1.56 Million
63,536 Added 538.4%
75,337 $1.79 Million
Q4 2023

Feb 12, 2024

SELL
$11.39 - $21.67 $9,840 - $18,722
-864 Reduced 6.82%
11,801 $255,000
Q3 2023

Nov 14, 2023

SELL
$14.52 - $21.77 $2,090 - $3,134
-144 Reduced 1.12%
12,665 $183,000
Q2 2023

Aug 14, 2023

BUY
$19.35 - $22.31 $247,854 - $285,768
12,809 New
12,809 $268,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $1.07B
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.